Disease- and sex-specific differences in patients with heart valve disease: a proteome study
Authors:
- Sarah NordmeyerSNSarah Nordmeyer
- Milena KrausMKMilena Kraus
- Matthias ZiehmMZMatthias Ziehm
- Marieluise KirchnerMKMarieluise Kirchner
- Marie SchafsteddeMSMarie Schafstedde
- Istvan BaczkoIBIstvan Baczko
- Christoph KnosallaCKChristoph Knosalla
- Matthieu-P SchapranowMSMatthieu-P Schapranow
- Gunnar DittmarGunnar Dittmar
Open Access
- 10 January 2023
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (3) , e202201411
Abstract
Pressure overload in patients with aortic valve stenosis and volume overload in mitral valve regurgitation trigger specific forms of cardiac remodeling; however, little is known about similarities and differences in myocardial proteome regulation. We performed proteome profiling of 75 human left ventricular myocardial biopsies (aortic stenosis = 41, mitral regurgitation = 17, and controls = 17) using high-resolution tandem mass spectrometry next to clinical and hemodynamic parameter acquisition. In patients of both disease groups, proteins related to ECM and cytoskeleton were more abundant, whereas those related to energy metabolism and proteostasis were less abundant compared with controls. In addition, disease group–specific and sex-specific differences have been observed. Male patients with aortic stenosis showed more proteins related to fibrosis and less to energy metabolism, whereas female patients showed strong reduction in proteostasis-related proteins. Clinical imaging was in line with proteomic findings, showing elevation of fibrosis in both patient groups and sex differences. Disease- and sex-specific proteomic profiles provide insight into cardiac remodeling in patients with heart valve disease and might help improve the understanding of molecular mechanisms and the development of individualized treatment strategies.Keywords
Funding Information
- German Federal Ministry of Education and Research (031A427A, 031A427B, 031A427C, 031A427D, 01ZZ1802H)
- ERA-CVD
- CRC1470
- European Commission (689617)
- Deutsche Forschungsgemeinschaft (SFB-1470, project Z03, B05)
- Charité – Universitätsmedizin, Berlin
- Ministry of Human Capacities, Hungary (20391-3/2018/FEKUSTRATD)
This publication has 56 references indexed in Scilit:
- Cardiac Metabolism in Heart FailureCirculation Research, 2013
- Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart diseaseFibrogenesis & Tissue Repair, 2012
- Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat HeartJournal of Biological Chemistry, 2012
- Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast PhenotypeJournal of Biological Chemistry, 2011
- αB-Crystallin Suppresses Pressure Overload Cardiac HypertrophyCirculation Research, 2008
- Thrombospondin-4 expression is rapidly upregulated by cardiac overloadBiochemical and Biophysical Research Communications, 2008
- Identification of Cardiac-Specific Myosin Light Chain KinaseCirculation Research, 2008
- Adjusting batch effects in microarray expression data using empirical Bayes methodsBiostatistics, 2006
- Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena?International Journal of Cardiology, 1991
- Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosisThe American Journal of Cardiology, 1988